title: [The influence of hepatoprotector 2-ethylthiobenzimidazole hydrobromide (bemithyl) on the content of glycogen in cirrhotic rat liver hepatocytes located in various microenvironments].
abstract: Using absorption and fluorescent cytophotometry methods, glycogen contents were studied in hepatocytes located in liver lobules and in hepatocytes, which make the general population of these cells in normal and cirrhotic rat liver. In cirrhosis, the content of glycogen in hepatocytes located in lobules obviously rises in comparison with the norm, but to a lesser degree, than in hepatocytes making the general population of these cells in cirrhotic liver. The content of glycogen in hepatocytes, located in lobules of pathologically changed liver in bemithyl treated rats, did not differ from the norm. At the same time, the glycogen content in hepatocytes, representing the general population of these cells in cirrhotically altered bemithyl injected rat liver, remained higher than in the norm. The data obtained indicate that distinctions in particular cell microinvironment, obviously present in cirrhotic liver, render essential influence on hepatocyte functional activity.
authors.forename: M V
authors.initials: MV
authors.lastname: Kudriavtseva
authors.forename: N N
authors.initials: NN
authors.lastname: Bezborodkina
authors.forename: S V
authors.initials: SV
authors.lastname: Okovityĭ
authors.forename: B N
authors.initials: BN
authors.lastname: Kudriavtsev
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology*; D005434:Flow Cytometry; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D007274:Injections, Intraperitoneal; D008106:Liver Cirrhosis, Experimental / Q000188:drug therapy* / Q000378:metabolism; D008112:Liver Glycogen / Q000032:analysis / Q000378:metabolism*; D008297:Male; D051381:Rats; D013194:Staining and Labeling
chemical_list: D000975:Antioxidants; D001562:Benzimidazoles; D008112:Liver Glycogen; C049825:bemethyl